Cargando…
Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial
This was a phase I clinical trial to investigate the safety of autologous peripheral-blood-derived CD34+ cell therapy for patients with chronic kidney disease (CKD-treatment) (i.e., at Stages III and IV). Between November 2014 and October 2015, a total of 10 study patients were prospectively enrolle...
Autores principales: | Lee, Mel S., Lee, Fan-Yen, Chen, Yung-Lung, Sung, Pei-Hsun, Chiang, Hsin-Ju, Chen, Kuan-Hung, Huang, Tien-Hung, Chen, Yi-Ling, Chiang, John Y., Yin, Tsung-Cheng, Chang, Hsueh-Wen, Yip, Hon-Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392283/ https://www.ncbi.nlm.nih.gov/pubmed/28148896 http://dx.doi.org/10.18632/oncotarget.14831 |
Ejemplares similares
-
Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke—evaluating the impact of therapeutic time points on prognostic outcomes
por: Lin, Kun-Chen, et al.
Publicado: (2020) -
Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open‐label, controlled phase II clinical trial
por: Yang, Chih‐Chao, et al.
Publicado: (2020) -
Overexpression of miR‐19a and miR‐20a in iPS‐MSCs preserves renal function of chronic kidney disease with acute ischaemia‐reperfusion injury in rat
por: Lee, Mel S., et al.
Publicado: (2021) -
Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance—A Randomized, Open-Label, Controlled Phase II Clinical Trial
por: Sung, Pei-Hsun, et al.
Publicado: (2020) -
Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis
por: Lee, Fan-Yen, et al.
Publicado: (2017)